Young children with acute lymphoblastic leukemia (ALL) appeared to experience anxiety around medical procedures in their first 1.5 years after diagnosis that seemed to decrease over time, according to ...

Maintenance with niraparib and bevacizumab can be effective in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor.

HealthDay News — Overall cancer mortality rates declined from 2001 through 2022, while cancer incidence rates decreased from 2001 through 2013 and stabilized through 2021, according to the 2024 Annual ...